C Hasan
Overview
Explore the profile of C Hasan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
337
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fleischhack G, Cipic D, Juettner J, Hasan C, Bode U
Intensive Care Med
. 2008 May;
26 Suppl 2:S202-11.
PMID: 18470721
Objective: Sensitive parameters of inflammations, are rare or of limited validity in neutropenic patients. Procalcitonin (PCT) proven to be a sensitive inflammatory marker in nonneutropenic patients was evaluated for its...
2.
Simon A, Fleischhack G, Wiszniewsky G, Hasan C, Bode U, Kramer M
Infection
. 2006 Oct;
34(5):258-63.
PMID: 17033749
Background: To assess the effects of extending the routine intravenous administration set (IVAS) change-interval from 72 h (group 1) to 7 days (group 2) on the incidence density for central...
3.
Buchen S, NGampolo D, Melton R, Hasan C, Zoubek A, Henze G, et al.
Br J Cancer
. 2005 Jan;
92(3):480-7.
PMID: 15668713
The methotrexate (MTX) rescue agent carboxypeptidase G2 (CPDG2) rapidly hydrolyses MTX to the inactive metabolite DAMPA (4-[[2,4-diamino-6-(pteridinyl)methyl]-methylamino]-benzoic acid) and glutamate in patients with MTX-induced renal failure and delayed MTX excretion....
4.
Tenenbaum T, Hasan C, Kramm C, JANSSEN G, Laws H, Wessalowski R, et al.
Onkologie
. 2004 May;
27(2):131-7.
PMID: 15138344
Objectives: Aim of this study was to analyze the feasibility of oncological treatment in pediatric patients belonging to Jehovah's Witnesses and to describe the changing policy in performing transfusions and...
5.
Bokenkamp A, Grabensee A, Stoffel-Wagner B, Hasan C, Henne T, Offner G, et al.
Clin Nephrol
. 2003 Jan;
58(6):417-22.
PMID: 12508963
Background: As a consequence of more intensified immunosuppression, post-transplant lymphoproliferative disease (PTLD) is increasingly observed in patients after solid-organ transplantation. Beta2-microglobulin, a low-molecular weight protein (MW 11.8 kDa), is produced...
6.
Kremens B, Gruhn B, Klingebiel T, Hasan C, Laws H, Koscielniak E, et al.
Bone Marrow Transplant
. 2002 Dec;
30(12):893-8.
PMID: 12476282
Children with Wilms tumor who have a particular risk of failure at relapse or at primary diagnosis were treated with high-dose chemotherapy (HDC) and autologous peripheral blood stem cell rescue...
7.
Hasan C, Bode U, Fleischhack G
Mycoses
. 2002 Jul;
45(5-6):170-3.
PMID: 12100534
Though liposomal amphotericin B has been available in Germany since 1992, efficacy and safety of this formulation of amphotericin B are still not well-documented in children. As far as gastrointestinal...
8.
Hettmer S, Fleischhack G, Hasan C, Kral T, Meyer B, Bode U
Pediatr Hematol Oncol
. 2002 Jun;
19(5):347-54.
PMID: 12078866
Involvement of the central nervous system in osteosarcoma is uncommon. These neoplasms are most often located at the metaphyses of tubular bones and rarely in flat bones of vertebra, ribs,...
9.
Fleischhack G, Theuerkauf I, LUDWIG K, Simon A, Hasan C, Bode U
Med Pediatr Oncol
. 2002 Jan;
38(2):120-3.
PMID: 11813179
No abstract available.
10.
Fleischhack G, Wulff B, Havers W, Marklein G, Hasan C, Bode U
Support Care Cancer
. 2001 Aug;
9(5):372-9.
PMID: 11497392
The beta-lactam/beta-lactamase inhibitor combinations are a good choice for empirical antimicrobial therapy in febrile neutropenic patients, because their antibacterial spectra include both gram-negative and gram-positive pathogens. This trial was initiated...